We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boston Scientific Corporation's new Guidant unit is facing about 300 class-action and individual lawsuits related to problems with Guidant heart devices that became public last year, Boston Scientific disclosed in a regulatory filing Wednesday.
RCP Diagnostics announced today that they have entered into a licensing agreement with Biomarker Technologies to allow Biomarker to use RCP's protein marker, riboflavin carrier protein, in conjunction with Biomarker's blood diagnostic for breast cancer, called the BT Test.
Maxxon, Inc., a growing medical products designer, manufacturer, and distributor concentrating on innovative Safety-engineered medical devices (SEMDs) that will have a price advantage over many competitors in the SEMDs arena, announces that Globe Med Tech has been working on a user/lab study to determine the optimum retraction activation force for its Maxxon 3 cc Vacuum Operated Retractable Safety Syringe ("ReVac") plunger.
Boston Scientific Corp. and BioForm Medical Inc., report that the Food and Drug Administration has approved BioForm Medical's injectable implant for the treatment of female stress urinary incontinence.
The U.S. Court of Appeals for the Federal Circuit sided with Cardium Therapeutics in the firm's patent dispute with Arch Development and its licensee, Boston Scientific, Cardium reported.
Angiotech Pharmaceuticals Inc., best known for its drug-coated stents, reported lower profits Tuesday but said it has signed a deal to develop cancer treatments with U.S. biotechnology company Genzyme (Nasdaq:GENZ).
The Gender Solutions(TM) High-Flex Knee, the first knee replacement shaped to fit a woman's anatomy, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).